Biggest World Pharma Company is based in the US, while the remaining five hail from Switzerland, the UK and France. Pharmaceutical-technology.com profiles the world’s ten biggest pharmaceutical companies of 2014 based on Forbes calculation of net market capitalisation, assets, sales and profit.
US-based global biopharmaceutical company Pfizer held $203.93bn in market capitalisation and $172.1bn worth assets as of May 2014. The company, which produces diverse healthcare products including human and animal biologic and small molecule medicines and vaccines, as well as nutritional products, recorded sales of $52.67bn and profit of $22bn in 2013.
Swiss multinational pharmaceutical company Novartis had a market value of $227.44bn and $126.3bn worth assets as of May 2014. With its diversified global health care portfolio of patent protected prescription medicines, generic pharmaceuticals, preventive vaccines, diagnostic tools, and animal and consumer healthcare products, the company recorded sales of $57.9bn and a profit of $9.2bn in 2013.
French multinational pharmaceutical company Sanofi was estimated to hold $137.14bn of market cap and $132.4bn of assets as of May 2014. The company, which is engaged in the research, production and distribution of pharmaceutical products, recorded net sales of $43.75bn and recorded a profit of $4.9bn in 2013.
Roche Holding, Switzerland
Roche Holding, a Switzerland-based holding company that manufactures, develops and markets diagnostic and therapeutic products, held $253.74bn of market capitalisation and assets worth $69.9bn as of May 2014. The company’s net sales and profit in 2013 stood at $50.46bn and $12bn respectively.
UK-based global healthcare company GlaxoSmithKline held a $128.8bn market cap and $69.7bn of assets as of May 2014. The company, operating in three primary areas of business – Pharmaceuticals, Vaccines and Consumer Healthcare – recorded sales of $41.43bn and profit of $8.5bn in 2013.
Eli Lilly & Co., USA
US-based pharmaceutical company Eli Lilly & Co. held $65.86bn market capitalisation and $35.2bn of assets as of May 2014, while its sales and net profit in 2013 were $23.11bn and $4.7bn respectively. Eli Lilly is a manufacturer of famous Cialis – treatment for ED. There are also popular generics drugs like Super Cialis.